UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000002456
Receipt No. R000003008
Scientific Title Phase II study of lapatinib plus capecitabin for the HER2 overexpressing metastatic breast cancer patients pretreated with oral-FU agents.
Date of disclosure of the study information 2009/09/07
Last modified on 2017/11/30 18:04:58

No. Disposal Last modified on Item of update
1 Insert 2009/09/06 16:52:12
2 Update 2010/09/06 12:31:50 Recruitment status
3 Update 2011/09/06 22:17:14 Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2011/09/06 22:21:16 Last follow-up date
5 Update 2014/03/06 10:41:49 Last name of lead principal investigator
Last name of lead principal investigator
Email
6 Update 2015/02/16 19:10:38 Recruitment status
Last follow-up date
7 Update 2017/11/30 18:04:58 UMIN ID1


Contact us.